Liminal BioSciences Acquisitions

Liminal BioSciences has acquired 3 companies and its latest acquisition was Fairhaven Pharmaceuticals Inc. on Jul 2020

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Fairhaven Pharmaceuticals Inc.

Jul 2020

Source »
$5.9M
-
Telesta Therapeutics

Aug 2016

Source »
$32.8M
Telesta Therapeutics is a biotechnology firm that develops and markets therapeutics for the treatment of cancer and immune diseases.
Emergent Biosolutions, Inc.

May 2015

Source »
undisclosed
Emergent is a Maryland-based pharmaceutical company that researches and develops vaccines and antibody therapies for the treatment of infectious diseases.

Frequently Asked Questions about Liminal BioSciences

  1. What companies did Liminal BioSciences acquire?

    Companies acquired by Liminal BioSciences include , Telesta Therapeutics and Emergent
  2. How many acquisitions does Liminal BioSciences have?

    Liminal BioSciences has acquired 3 companies including , Telesta Therapeutics and Emergent.
  1. How many acquisitions did Liminal BioSciences make in 2020?

    In 2020 Liminal BioSciences acquired 1 companies including undefined.